Accès ouvert
2026
article
OpenAlex
Colette J. Shen, Andrew F. Voter, Hyunseok Kang, Rajni Sharma et autres
Adenoid cystic carcinoma (ACC) is a rare malignancy of the salivary glands with poor long-term outcomes and with a need for improved imaging and therapeutic options. Prostate-specific membrane antigen (PSMA) expression has been observed in ACC and preliminary studies have demonstrated PET …
us
(code pays fourni par la source)
2026
article
OpenAlex
Carolina Gomes-Alexandre, Tamara Lotan, Charles J. Bieberich, Andrew F. Voter et autres
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Koichiro Kimura, Vishnu Murthy, Andrew F. Voter, Lilja B. Sólnes et autres
Pretherapeutic visual and quantitative indicators derived from prostate-specific membrane antigen (PSMA) PET/CT have been proposed as predictors of response to [177Lu]Lu-PSMA-617 (177Lu-PSMA) therapy in patients with metastatic castration-resistant prostate cancer. This study aimed to evaluate and compare the prognostic performance of these …
us, de
(code pays fourni par la source)
2025
article
OpenAlex
Linmei Zhao, Maliha R. Imami, Yuli Wang, Yitao Mao et autres
us, cn, tw
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Adenine Si-Hui Koo, Weiyan Jia, Sang Hwa Kim, Mark A. Scalf et autres
How RIF1 (RAP1 interacting factor 1) fulfills its diverse roles in DNA double-strand break repair, DNA replication, and nuclear organization remains elusive. Here, we show that alternative splicing of a cassette exon (Ex32) encoding a Ser/Lys-rich cassette in the RIF1 C-terminal domain …
us
(code pays fourni par la source)
2025
article
OpenAlex
Stephan Skawran, Andrei Gafita, Theo Lorenzini, Robert Tauber et autres
Prostate-specific membrane antigen (PSMA) PET has the potential to monitor the response to taxane-based chemotherapy in patients with prostate cancer and shows promise for predicting outcomes and improving response evaluation. This retrospective study aimed to determine the prognostic value of [68Ga]Ga-PSMA-11 PET …
ch, de, us, it, fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Avina Rami, Caiwei Zhong, Miguel Muniz, Wanling Xie et autres
Lu]Lu-PSMA-617 (LuPSMA) across racial groups. We evaluated the association between race and outcomes with LuPSMA in a multi-institutional cohort of consecutive patients with mCRPC treated with LuPSMA. The primary outcomes were PSA-50 rate, PSA-progression-free survival (PSA-PFS), and overall survival (OS). Statistical models …
us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Koichiro Kimura, Vishnu Murthy, Andrew F. Voter, Abuzar Moradi Tuchayi et autres
5079 Background: 177 Lu-PSMA-617 (Lu-PSMA) contributes to prolong progression-free survival (PFS) and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients who progressed after chemotherapy. Pretherapeutic prostate-specific membrane antigen (PSMA) PET/CT information can be used to predict Lu-PSMA therapy response patterns …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Andrew F. Voter, Alireza Amindarolzarbi, Colette J. Shen, Jarey H. Wang et autres
Adenoid cystic carcinoma (ACC) is a rare malignancy of the salivary glands with poor long-term outcomes and with a need for improved imaging and therapeutic options. Prostate-specific membrane antigen (PSMA) expression has been observed in ACC and preliminary studies have demonstrated PET …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Rachel R. Cueny, Andrew F. Voter, Aidan M. McKenzie, Marcel Morgenstern et autres
G-quadruplex (G4) structures can form in guanine-rich DNA or RNA and have been found to modulate cellular processes, including replication, transcription, and translation. Many studies on the cellular roles of G4s have focused on eukaryotic systems, with far fewer probing bacterial G4s. …
us
(code pays fourni par la source)
2025
article
OpenAlex
Andrew F. Voter
us
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Stephan Skawran, Andrei Gafita, Theo Lorenzini, Sebastian Hoberück et autres
33 Background: PSMA-PET/CT is increasingly being used to monitor chemotherapy in prostate cancer and shows promise for predicting outcomes and improving response evaluation. This retrospective study aimed to determine the prognostic value of quantitative tumor burden parameters derived from PSMA-PET/CT for overall …
ch, us, de, it, fr
(code pays fourni par la source)